Research field (3)：
Clinical pharmacy
, Pharmacology
, Pharmaceuticals - health and biochemistry
Research keywords (1)：
分子生物学
Research theme for competitive and other funds (1)：
2011 - 2013 Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia
Papers (24)：
Miki Yamaguchi, Sachie Hirai, Masashi Idogawa, Toshiyuki Sumi, Hiroaki Uchida, Yuji Sakuma. A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells. International journal of molecular sciences. 2024. 25. 16
Yuji Sakuma, Sachie Hirai, Miki Yamaguchi, Masashi Idogawa. Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival. International journal of molecular sciences. 2024. 25. 13
Yuji Sakuma, Sachie Hirai, Toshiyuki Sumi, Toshiro Niki, Miki Yamaguchi. Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells. Biochemical and biophysical research communications. 2023. 678. 84-89
Miki Yamaguchi, Sachie Hirai, Masashi Idogawa, Toshiyuki Sumi, Hiroaki Uchida, Naoki Fujitani, Motoko Takahashi, Yuji Sakuma. Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma. Experimental cell research. 2023. 426. 2. 113570-113570
Sachie Hirai, Masashi Idogawa, Toshiyuki Sumi, Miki Yamaguchi, Toshiro Niki, Yuji Sakuma. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells. Biochemical and biophysical research communications. 2022. 630. 24-29
